Financial Results, Grants and New Mobile Features, and Dividend - Research Reports on Western Union, CME, Charles Schwab, Equity Residential and Health Care REIT

NEW YORK, November 5, 2014 /PRNewswire/ --

Today, Analysts Review released its research reports regarding The Western Union Company (NYSE: WU), CME Group Inc. (NASDAQ: CME), The Charles Schwab Corporation (NYSE: SCHW), Equity Residential (NYSE: EQR) and Health Care REIT, Inc. (NYSE: HCN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7703-100free.

--
The Western Union Company Research Reports
On October 30, 2014, The Western Union Company (Western Union) released its Q3 2014 and 9M 2014 financial results. The Company reported 2.3% YoY improvement in its Q3 2014 total revenues to $1.44 billion, while operating income for the quarter improved 6.4% YoY to $314.1 million. The Company's Q3 2014 net income came in at $234.1 million or $0.44 per diluted share, compared to net income of $214.4 million or $0.39 per diluted share in Q3 2013. Analysts polled by Thomson Reuters anticipated Western Union to report EPS of $0.38 on revenue of $1.43 billion in the quarter. The Company's 9M 2014 total revenues improved 1.9% YoY to $4.2 billion and net income was $630.9 million, up 0.9% YoY. For full-year 2014, the Company expects GAAP EPS of $1.50, and GAAP operating margin of approximately 20%. The full research reports on Western Union are available to download free of charge at:

http://www.analystsreview.com/Nov-05-2014/WU/report.pdf

--
CME Group Inc. Research Reports
On October 30, 2014, CME Group Inc. (CME) reported Q3 2014 total revenues of $762.4 million, up 6.7% YoY, helped by 7.3% YoY growth in Clearing and transaction fees to $641.8 million. The Company's Q3 2014 net income attributable to CME stood at $290 million or $0.86 per diluted share, compared to net income of $236.7 million or $0.71 per diluted share in Q3 2013. The Company's Q3 2014 adjusted EPS came in at $0.84. On average, analysts polled by Thomson Reuters expected the Company to report EPS (excluding special items) of $0.83 on revenues of $764.99 million for the quarter. The Company reported 9M 2014 total revenues improved 1.0% YoY to $2.3 billion, while net income attributable to CME improved 4.7% YoY to $820.6 million. The Company expects adjusted operating expenses to be c.$1.3 billion for both full-year 2014 and 2015. The full research reports on CME are available to download free of charge at:

http://www.analystsreview.com/Nov-05-2014/CME/report.pdf

--
The Charles Schwab Corporation Research Reports
On October 30, 2014, Schwab Charitable announced that it has made over $4.6 billion in grants on behalf of its donors to more than 86,000 charities since its inception 15 years ago. Schwab Charitable reported that till the date of reporting in FY 2015 (period ending June 30, 2015) it has witnessed 55% YoY growth in grants. Schwab Charitable further expects grants figure to cross $1 billion mark at the end of FY 2015. In addition, Schwab Charitable also introduced new mobile and online features that will further encourage philanthropy this giving season by making tax-smart giving simple and even more accessible. Clients may now recommend grants from their charitable accounts on their iPads, iPhones and Android devices using the Schwab Mobile App. Schwab Charitable is the name used for the combined programs and services of Schwab Charitable Fund, an independent nonprofit organization, which has entered into service agreements with certain affiliates of The Charles Schwab Corporation. The full research reports on Charles Schwab are available to download free of charge at:

http://www.analystsreview.com/Nov-05-2014/SCHW/report.pdf

--
Equity Residential Research Reports
On October 28, 2014, Equity Residential (Equity Residential) reported Q3 2014 funds from operations (FFO) per diluted share of $0.81, compared to FFO per diluted share of $0.71 in Q3 2013. The Company's Q3 2014 total revenues improved 6.0% YoY to $664.1 billion, led by 6.1% YoY improvement in rental income to $662.0 million. The Company's Q3 2014 net income available to common shares stood at $220.7 million or $0.61 per diluted share, compared to net income of $376.2 million or $1.05 per diluted share in Q3 2013, primarily due to higher gains on property sales in Q3 2013, partially offset by higher depreciation expense in Q3 2013. The Company's 9M 2014 total revenues improved 11.5% YoY to $2.0 billion, while net income available to common shares declined 76.1% YoY to $410.5 million. The Company expects Q4 2014 Normalized FFO in the range of $0.81 - $0.83 per share, while for full-year 2014, the Company expects Normalized FFO between $3.12 and $3.14 per share. The full research reports on Equity Residential are available to download free of charge at:

http://www.analystsreview.com/Nov-05-2014/EQR/report.pdf

--
Health Care REIT, Inc. Research Reports
On October 30, 2014, Health Care REIT, Inc. (Health Care REIT) announced that the Company's Board of Directors has declared Q3 2014 cash dividend of $0.795 per share, payable November 20, 2014, to stockholders of record on November 10, 2014. The full research reports on Health Care REIT are available to download free of charge at:

http://www.analystsreview.com/Nov-05-2014/HCN/report.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is produced on a best efforts basis by Rohit Tuli, a CFA charterholder. The content is then further fact checked and reviewed by an outsourced research provider. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED